Table 1 Baseline characteristics of the participants
Group I (67 cases) | Group II (60 cases) | P value | ||
|---|---|---|---|---|
Age | Mean ± SD | 56.65 ± 8.28 | 56.78 ± 7.80 | 1.000 |
Body mass index | Mean ± SD | 30.14 ± 3.25 | 30.62 ± 3.30 | 0.986 |
Age groups, year, n (%) | ˂ 50 | 8 (11.9) | 9 (15 | |
50–65 | 51 (76.2) | 43 (71.7) | ||
˃ 65 | 8 (11.9) | 8 (13.3) | 0.831 | |
Sex, n (%) | Female | 44 (65.7) | 36 (60) | |
Male | 23 (34.3) | 24 (40) | 0.509 | |
Body mass index, n (%) | Normal | 3 (4.5) | 4 (6.7) | |
Overweight | 29 (43.3) | 18 (30) | ||
Obese | 30 (44.8) | 32 (53.3) | ||
Morbid obesity | 5 (7.4) | 6 (10) | 0.479 | |
Diabetes mellitus, n (%) | 42 (62.7) | 40 (66.7) | 0.640 | |
Chronic kidney disease, n (%) | 3 (4.5) | 5 (8.3) | 0.475 | |
Smoking, n (%) | 22 (32.8) | 27 (40) | 0.160 | |
Peripheral ischemia, n (%) | 44 (65.7) | 38 (63.3) | 0.783 | |
Hypercholesterolemia, n (%) | 52 (77.6) | 43 (71.7) | 0.441 | |
Coagulopathy or use of anticoagulation, n (%) | 50 (74.6) | 47 (78.3) | 0.623 | |
Serum albumin level (low) ˂ 30 mmol/l, n (%) | 30 (44.8) | 28 (46.7) | 0.831 | |